x

#BCSM Blog

ASBrS 2017 – Key Topics by Dr. Deanna Attai
By: Alicia
May 8, 2017

Dr. Shelley Hwang from Duke University spoke on DCIS subtyping and overtreatment. She noted that DCIS now comprises over 20% of all mammographically detected breast cancer. It is considered a “non-obligate precursor” of invasive cancer – the rate and likelihood of progression to invasive cancer are not clearly known. However, it is clear that some […]

Read more ›
ASBrS 2017: Oncoplastics and Adequate Margins
On: May 8, 2017
By: Alicia

This guest post is from Dr. Aleksandra Popadich.  Dr. Popadich came all the way to Las Vegas from New Zealand because she watched Dr. Attai’s tweets from the 2016 conference! Oncoplastic surgery is going to become a part of breast surgeon’s repertoire. The development of these skills will enable us to achieve good local control and […]

Read more ›
ASBrS 2017: Contralateral Prophylactic Mastectomy (CPM)
On: May 8, 2017
By: Alicia

ASBrS17: Contralateral Prophylactic Mastectomy (CPM) This guest post is by Dr. Diane Radford. The American Society of Breast Surgeons published a consensus statement on CPM in which it was stated that average-risk women with unilateral breast cancer do not derive any oncologic benefit from CPM, and thus CPM should be discouraged (Annals of Surgical Oncology […]

Read more ›
ASBrS 2017 Lymphedema Panel
On: May 8, 2017
By: Alicia

Thank you to Dr. Kimberli Cox for submitting this review of the Lymphedema Panel at ASBRS 2017. The panel, a multidisciplinary (breast surgeons, plastic surgeons, radiation oncology, LE therapists, PMR and our own Alicia Staley) international group presented their findings and recommendations. Stated goals were recognizing the issue, the possible lack of a definitive solution, […]

Read more ›
ASBrS 2017 – Advances in Staging
On: May 8, 2017
By: Alicia

“So, what stage am I?” This guest post is by Dr. Jaime Lewis This question and the answer helps providers and patients in understanding the extent of disease and prognosis, guiding appropriate treatment, and clustering patients in studies and guidelines. It allows us to communicate regarding groups of patients believed to be similar. The staging […]

Read more ›